NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









VoxCell BioInnovation

VoxCell BioInnovation

Private
VictoriaHealthcare & Life Scienceshttps://voxcell.com/

Last Round

Grant

May 30, 2025

Total Funding Raised

$2.18M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

VoxCell BioInnovation is a biotechnology company that develops 3D bioprinted, vascularized human-like tissue models to enhance drug development and testing accuracy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, 3D Printing, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

3D bioprintingvascularized tissue modelsdrug discoverybio-inksorgan-on-a-chipin vitro testingtissue engineeringpreclinical drug trialsbiotech equipmentcontract research organizationCROtoxicology testingnew approach methodologiesNAMsregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VoxCell BioInnovation Comparables

Compare VoxCell BioInnovation with similar companies based on industry and business-model similarity.

VoxCell BioInnovation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brinter
86%
Aspect Biosystems
84%
Inventia Life Science
83%

VoxCell BioInnovation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 30, 2025
GrantFeb 12, 2025
SeedNov 15, 2024
GrantSep 26, 2023
SeedNov 30, 2022
Grant
Oct 3, 2022

VoxCell BioInnovation Investors

Notable investors and investment history

VoxCell BioInnovation investors
InvestorRounds
Sustainable Development Technology CanadaGrant
WUTIF Management CorporationPre Seed
Women's Equity LabPre Seed
Archangel NetworkPre Seed
SpringSeed
Innovate BCGrant
E-FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    CEO received an Emerging Alumni Award from the University of Victoria.

  • Jan 18, 2026

    Graham Craig appointed as the new CCO.

VoxCell BioInnovation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VoxCell BioInnovation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VoxCell BioInnovation's valuation, stock price, and market status.

Firmographic Details

HeadquartersVictoria
Employee Range29
Year Founded2020
Last FundingMay 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.